HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,258 | -87.1% | 46 | -91.2% | 0.00% | – |
| Q1 2023 | $9,760 | +74976.9% | 525 | +4.2% | 0.00% | – |
| Q4 2022 | $13 | -100.0% | 504 | -70.6% | 0.00% | -100.0% |
| Q3 2022 | $38,000 | +111.1% | 1,717 | +87.9% | 0.00% | 0.0% |
| Q2 2022 | $18,000 | -5.3% | 914 | -3.0% | 0.00% | – |
| Q1 2022 | $19,000 | +1800.0% | 942 | +3264.3% | 0.00% | – |
| Q4 2021 | $1,000 | -98.7% | 28 | -98.5% | 0.00% | -100.0% |
| Q3 2021 | $78,000 | -11.4% | 1,865 | -3.0% | 0.00% | 0.0% |
| Q2 2021 | $88,000 | -28.5% | 1,922 | -34.7% | 0.00% | 0.0% |
| Q1 2021 | $123,000 | +23.0% | 2,942 | +26.6% | 0.00% | -50.0% |
| Q4 2020 | $100,000 | – | 2,324 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2018 | $132,000 | -35.6% | 9,225 | -18.4% | 0.01% | 0.0% |
| Q3 2018 | $205,000 | +9.6% | 11,300 | +2.0% | 0.01% | 0.0% |
| Q2 2018 | $187,000 | -31.0% | 11,075 | -17.2% | 0.01% | -33.3% |
| Q1 2018 | $271,000 | 0.0% | 13,375 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $271,000 | +34.2% | 13,375 | +14.9% | 0.01% | +50.0% |
| Q3 2017 | $202,000 | +7.4% | 11,636 | -20.8% | 0.01% | 0.0% |
| Q2 2017 | $188,000 | +0.5% | 14,686 | +1.6% | 0.01% | -11.1% |
| Q1 2017 | $187,000 | +78.1% | 14,460 | +36.3% | 0.01% | +80.0% |
| Q4 2016 | $105,000 | -4.5% | 10,610 | +16.5% | 0.01% | -16.7% |
| Q3 2016 | $110,000 | +14.6% | 9,111 | -17.7% | 0.01% | +20.0% |
| Q2 2016 | $96,000 | +95.9% | 11,077 | +290.6% | 0.01% | +66.7% |
| Q4 2015 | $49,000 | – | 2,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |